Welcome to our dedicated page for Atomera SEC filings (Ticker: ATOM), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Atomera Incorporated filings document the company's semiconductor technology licensing business, Nasdaq-listed common stock, and material-event disclosures. Current reports furnish quarterly and annual financial results, investor presentations, Regulation FD communications, and capital-structure information related to common stock and registered securities.
Proxy and governance filings cover annual meeting procedures, shareholder voting matters, board and bylaw provisions, and other corporate-governance disclosures. The record also includes amendments to bylaws, including meeting quorum and voting-requirement changes, alongside formal exhibits used to report operating results, material agreements, and other public-company events.
Atomera Inc CEO and President Scott A. Bibaud received three performance stock option grants covering a total of 341,840 shares of common stock at an exercise price of $5.10 per share. These options expire on March 11, 2036.
The awards vest only if both time- and performance-based conditions are met. For each grant, 25% is scheduled to vest on March 1, 2027, with the remaining 75% vesting in 12 equal quarterly installments thereafter, but only if the company’s average volume-weighted share price over any 30 consecutive trading days within five years from grant is at least $20.00, $12.50, or $7.50, depending on the specific tranche.
If the relevant stock price threshold for a tranche is not reached within five years from the grant date, none of the options in that tranche will vest and they will terminate at the end of that five-year period. These are compensation-related grants rather than open-market purchases.
Atomera Inc Chief Technology Officer Robert J. Mears reported both equity awards and related tax share sales in common stock. On March 2, 2026, he sold 3,979 shares at $4.95 per share in transactions described as mandatory "sell to cover" for tax withholding on vesting restricted stock.
On the same date, he was granted a total of 114,504 shares of common stock at no cost through restricted stock units and performance stock units. One restricted stock unit award vests 8.33% each quarter for 36 months starting June 1, 2026. The performance stock units vest on March 1, 2028 and March 1, 2029, respectively, if performance goals for periods from January 1, 2026 to December 31, 2027 and to December 31, 2028 are achieved. After these transactions, he directly owned 283,403 shares, with an additional 2,666 shares held indirectly by his spouse.
Atomera CFO Laurencio Francis reported multiple stock transactions in Atomera common stock. On March 2, 2026, he sold a total of 4,799 shares at $4.95 per share in open-market transactions.
According to the disclosure, these sales were made solely to cover tax withholding obligations arising from the vesting of previously granted restricted stock, under a mandatory, non-discretionary "sell to cover" arrangement pursuant to Rule 10b5-1(c)(1)(ii)(D)(3). On the same date, he also received several stock awards, including performance stock units and restricted stock units that each represent a right to receive one share of common stock, subject to future performance and time-based vesting conditions extending through March 2029.
Atomera Inc CEO and President Scott A. Bibaud reported a mix of equity awards and tax-related share sales. On March 2, 2026, he received several stock and performance-based stock unit grants at no cost, which will vest over multi‑year periods tied to performance and service. The same day, he sold 10,075 shares of common stock at $4.95 per share in open-market transactions to cover tax withholding obligations from previously vested restricted stock. After these transactions, his directly held common stock position was 709,741 shares.
Atomera Inc. notice of proposed sale of common stock by an insider. The filing lists 4,799 common shares tied to a vesting event on 03/01/2026 that were granted under the issuer's equity compensation plan, and records prior sales of 21,834 common shares on 02/20/2026 for $158,301.78.
ATOM filed a Form 144 reporting an intended sale of 3,979 common shares associated with the vesting of restricted stock granted under the issuer's equity compensation plan. The vesting event is dated 03/01/2026 and the filing is dated 03/02/2026. The transaction lists Morgan Stanley Smith Barney LLC as the broker and indicates NASDAQ as the market.
Morgan Stanley Smith Barney LLC Executive Financial Services reported the vesting of 10,075 shares of Common stock under the issuer's equity compensation plan with dates shown 03/01/2026 and 03/02/2026.
The filing lists this vesting alongside a Form 144 securities‑to‑be‑sold entry for Common stock on 03/02/2026; the shares were granted as part of the issuer's equity compensation plan.
Atomera Incorporated reported that CVI Investments, Inc. and Heights Capital Management, Inc. together hold 2,100,000 shares of common stock, representing 5.8% of the class. The filing states there were 36,509,895 shares outstanding as of the completion of the offering per the prospectus supplement filed 02/24/2026.
The filing notes CVI Investments is organized in the Cayman Islands and that Heights Capital Management, Inc., as CVI's investment manager, may exercise shared voting and dispositive power over those shares; both entities disclaim beneficial ownership except for pecuniary interest.
Atomera Incorporated describes its MST® silicon film technology and licensing model for the global semiconductor market, focusing on power, RF, CMOS and emerging compound semiconductor applications. The company licenses process technology, MSTcad® simulation software and integration engineering rather than manufacturing chips itself.
Atomera remains in an early commercialization stage with limited revenue and significant losses, reporting net losses of about $20.2 million in 2025 and an accumulated deficit of roughly $241.7 million. It spent approximately $12.3 million on research and development in 2025 and had about $19.2 million in cash and cash equivalents and working capital of about $17.6 million as of December 31, 2025, later raising roughly $23.6 million in a February 2026 stock offering.
The company highlights JDAs and integration licenses with major foundry, IDM and fabless partners but notes that STMicroelectronics paused qualification of MST in 2025. Atomera reports 21 employees, 119 U.S. and 130 foreign patents with extensive pending applications, and emphasizes cybersecurity, IP protection and risks tied to long adoption cycles, customer concentration, financing needs and stock volatility.
Atomera Incorporated is issuing 5,000,000 shares of common stock in a registered primary offering. The shares are being offered at $5.00 per share for aggregate gross proceeds of $25,000,000, with expected net proceeds of approximately $23,600,000 to be used for working capital and general corporate purposes.
The offering is being made pursuant to a prospectus supplement dated February 23, 2026, with delivery of shares expected on or about February 24, 2026. The company states there were 31,509,895 shares outstanding as of September 30, 2025, which gives an expected post-offering outstanding share count of 36,509,895 shares.